Latest Developments in Specialty Pharma India’s pharmaceutical industry has built a global reputation as a leading supplier of affordable generic medicines. Over the past two decades, Indian com...
Key Highlights Implications: Indoco is effectively cashing out of a non-core, lower-scale ophthalmic franchise (₹110 crore slump sale) to refocus capital and management on highe...
Key Highlights: Implications: EssilorLuxottica is using Essilor Stellest to move India’s pediatric myopia market from simple correction to active control, position...
Key Highlights: Implications: Anyra smashes Eylea pricing barriers, flooding retina clinics with budget-friendly therapy that keeps patients compliant for years. Zydus seizes op...
